Výsledky vyhledávání

Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group

Autor: D J, Diekema, M A, Pfaller, R N, Jones, G V, Doern, K C, Kugler, M L, Beach, H S, Sader

Publikováno v: International journal of antimicrobial agents. 13(4)

From January through June of 1998, 4579 bloodstream infections (BSI) due to bacterial pathogens were reported from SENTRY hospitals in Canada, the USA and Latin America. Staphylococcus aureus, Escherichia coli, and coagulase-negative staphylococcus (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ce3fd41039aa9b5fa02f0f3027dea7dd
https://pubmed.ncbi.nlm.nih.gov/10755240

Zobrazit plný text záznamu

Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study Group

Autor: R N, Jones, K C, Kugler, M E, Erwin, D J, Biedenbach, M L, Beach, M A, Pfaller

Publikováno v: Diagnostic microbiology and infectious disease. 33(4)

Gatifloxacin (formerly AM-1155 and CG5501), a new 8-methoxy fluoroquinolone, has an expanded spectrum of activity against Gram-positive cocci and some anaerobic bacteria. This compound was tested against 600 recent clinical strains of rapidly growing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a0b527d8e6d1b1cc608df0047ad8934a
https://pubmed.ncbi.nlm.nih.gov/10212751

Zobrazit plný text záznamu

Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group

Autor: H S, Sader, R N, Jones, A C, Gales, P, Winokur, K C, Kugler, M A, Pfaller, G V, Doern

Publikováno v: Diagnostic microbiology and infectious disease. 32(4)

Pneumonia is the most common fatal hospital-acquired infection, with attributable mortality rates ranging from 30 to 60%. Rapid initiation of optimal antimicrobial therapy is essential for obtaining treatment success. In this report the antimicrobial

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9a7cde9e225efec4db55c72b519096c0
https://pubmed.ncbi.nlm.nih.gov/9934546

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání